ADAMTS13 and acute kidney injury: Patients with severe ADAMTS13 deficiency also showed a trend for a higher proportion of bleeding (42% vs 13%) and cardiovascular signs and symptoms (11% vs 0%) and a lower proportion of renal failure (11% vs 38%), compared with those with ≥ 10%.